BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11205290)

  • 21. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection and biologic properties of malignant variants of a murine lymphosarcoma.
    Brunson KW; Nicolson GL
    J Natl Cancer Inst; 1978 Dec; 61(6):1499-503. PubMed ID: 281557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of immune responses to neem leaf extract (Azadirachta indica) correlates with antineoplastic activity in BALB/c-mice.
    Beuth J; Schneider H; Ko HL
    In Vivo; 2006; 20(2):247-51. PubMed ID: 16634526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.
    Suzuki E; Kim S; Cheung HK; Corbley MJ; Zhang X; Sun L; Shan F; Singh J; Lee WC; Albelda SM; Ling LE
    Cancer Res; 2007 Mar; 67(5):2351-9. PubMed ID: 17332368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
    Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
    Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001).
    Fujii Y; Iwasa H; Hirai J; Takahama Y; Hasumi K; Eriguchi M
    Biomed Pharmacother; 2000 Mar; 54(2):85-92. PubMed ID: 10759292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE
    Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
    Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
    Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models.
    Braun JM; Ko HL; Schierholz JM; Weir D; Blackwell CC; Beuth J
    Cancer Lett; 2001 Sep; 170(1):25-31. PubMed ID: 11448531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of macrophage-modulating agents on in vivo growth of transplantable Lewis lung cancer in mice.
    Nowicki A; Ostrowska G; Aukerman SL; Wiktor-Jedrzejczak W
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):313-7. PubMed ID: 7487373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.